A Look At Pharma ETFs Post Q4 Results

The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month. Here they are in detail.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.